DK1631569T3 - Quinuclidinderivater, der binder til muscariniske M3-receptorer - Google Patents

Quinuclidinderivater, der binder til muscariniske M3-receptorer

Info

Publication number
DK1631569T3
DK1631569T3 DK04730519T DK04730519T DK1631569T3 DK 1631569 T3 DK1631569 T3 DK 1631569T3 DK 04730519 T DK04730519 T DK 04730519T DK 04730519 T DK04730519 T DK 04730519T DK 1631569 T3 DK1631569 T3 DK 1631569T3
Authority
DK
Denmark
Prior art keywords
muscarinic
receptors
bind
quinuclidine derivatives
quinuclidine
Prior art date
Application number
DK04730519T
Other languages
Danish (da)
English (en)
Inventor
Stephen Paul Collingwood
Brian Cox
Urs Baettig
Gurdip Bhalay
Nicholas James Devereux
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1631569(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0324887A external-priority patent/GB0324887D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1631569T3 publication Critical patent/DK1631569T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK04730519T 2003-05-02 2004-04-30 Quinuclidinderivater, der binder til muscariniske M3-receptorer DK1631569T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0310232 2003-05-02
GB0324887A GB0324887D0 (en) 2003-10-24 2003-10-24 Organic compounds
PCT/EP2004/004605 WO2004096800A2 (fr) 2003-05-02 2004-04-30 Composes organiques

Publications (1)

Publication Number Publication Date
DK1631569T3 true DK1631569T3 (da) 2009-11-23

Family

ID=33420896

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04730519T DK1631569T3 (da) 2003-05-02 2004-04-30 Quinuclidinderivater, der binder til muscariniske M3-receptorer

Country Status (32)

Country Link
US (2) US20070060563A1 (fr)
EP (1) EP1631569B1 (fr)
JP (1) JP4416786B2 (fr)
KR (1) KR100896544B1 (fr)
AR (1) AR044134A1 (fr)
AT (1) ATE440840T1 (fr)
AU (1) AU2004234069B2 (fr)
BR (1) BRPI0410238A (fr)
CA (1) CA2523436C (fr)
CL (1) CL2004000918A1 (fr)
CO (1) CO5700782A2 (fr)
CY (1) CY1109655T1 (fr)
DE (1) DE602004022805D1 (fr)
DK (1) DK1631569T3 (fr)
EC (1) ECSP056134A (fr)
ES (1) ES2331185T3 (fr)
HK (1) HK1087704A1 (fr)
HR (1) HRP20050933A2 (fr)
IL (1) IL171591A (fr)
IS (1) IS2746B (fr)
MA (1) MA27775A1 (fr)
MX (1) MXPA05011739A (fr)
MY (1) MY142652A (fr)
NO (1) NO20055688L (fr)
NZ (1) NZ542995A (fr)
PE (1) PE20050465A1 (fr)
PL (1) PL1631569T3 (fr)
PT (1) PT1631569E (fr)
RU (1) RU2363700C2 (fr)
SI (1) SI1631569T1 (fr)
TW (1) TWI340139B (fr)
WO (1) WO2004096800A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239546B1 (es) * 2004-03-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos esteres de quinuclidina cuaternizados.
GB0410712D0 (en) 2004-05-13 2004-06-16 Novartis Ag Organic compounds
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0428416D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
EP1900737A1 (fr) * 2006-08-31 2008-03-19 Novartis AG Polymorphe de (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
EP1894568A1 (fr) * 2006-08-31 2008-03-05 Novartis AG Composées pharmaceutiques destinées au traitement des maladies inflammatoires ou obstructives des bronches
TW200825084A (en) * 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
CA2672446A1 (fr) * 2006-12-19 2008-06-26 Astrazeneca Ab Derives quinuclidinol utilises en tant qu'antagonistes du recepteur muscarinique
EP1950196A1 (fr) * 2007-01-29 2008-07-30 Boehringer Ingelheim Pharma GmbH & Co. KG Procédé de fabrication d'hexafluorophosphates d'ammonium
RU2480458C2 (ru) * 2007-09-07 2013-04-27 Тереванс, Инк. Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов
JP2011506477A (ja) 2007-12-14 2011-03-03 セラヴァンス， インコーポレーテッド ムスカリン受容体拮抗薬として有用なアミジン含有化合物
PT2231642E (pt) 2008-01-11 2014-03-12 Novartis Ag Pirimidinas como inibidores de quinase
GB0808709D0 (en) * 2008-05-13 2008-06-18 Astrazeneca Ab New combination 295
MX2010012019A (es) * 2008-05-13 2011-03-04 Astrazeneca Ab Producto farmaceutico que comprende un antagonista receptor muscarinico y un agonista de adrenoceptor beta2.
JP4837800B2 (ja) * 2008-05-13 2011-12-14 アストラゼネカ・アクチエボラーグ ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
US20090326004A1 (en) 2008-06-03 2009-12-31 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
WO2009153536A1 (fr) * 2008-06-17 2009-12-23 Argenta Discovery Limited Dérivés de 1-aza-bicyclo [2.2.2] octane utiles en tant qu’antagonistes des récepteurs muscariniques
GB0811100D0 (en) * 2008-06-17 2008-07-23 Astrazeneca Ab New combination
WO2011161018A1 (fr) * 2010-06-22 2011-12-29 Chiesi Farmaceutici S.P.A. Dérivés aminoester d'alcaloïdes et compositions médicinales les comprenant
WO2012034095A1 (fr) 2010-09-09 2012-03-15 Irm Llc Composés et compositions comme inhibiteurs de trk
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
CA2828219A1 (fr) 2011-02-25 2012-08-30 Irm Llc Composes et compositions en tant qu'inhibiteurs de trk
JP2011195593A (ja) * 2011-06-30 2011-10-06 Astrazeneca Ab ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
EP2797910B1 (fr) * 2011-12-30 2015-09-16 Chiesi Farmaceutici S.p.A. Esters de quinuclidine et d'acide 1-azahétérocyclylacétique utilisés comme agents antimuscariniques, procédé pour leur préparation et compositions médicinales correspondantes
US9687488B2 (en) 2012-05-03 2017-06-27 St. Louis College Of Pharmacy Compositions and methods for increasing neurotrophic peptides
TWI647227B (zh) * 2013-02-28 2019-01-11 日商安斯泰來製藥股份有限公司 ２－醯胺噻唑衍生物或其鹽
CZ306791B6 (cs) 2013-10-29 2017-07-12 Zentiva, K.S. Průmyslově využitelný způsob přípravy aklidinium bromidu o vysoké čistotě
PT108370B (pt) * 2015-03-30 2018-10-25 Hovione Farm S A Processo de preparação de brometo de aclidínio
EP3111978B1 (fr) 2015-07-03 2021-09-01 Novartis AG Inhalateur conçu pour lire des informations stockées dans un dispositif de stockage de données d'un récipient

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1219606A (en) * 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
DK534178A (da) * 1977-12-16 1979-06-17 Interx Research Corp Anticholinerge midler med sektrtionshaemmende virkning
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US6846835B2 (en) * 2000-07-11 2005-01-25 Banyu Pharmaceutical Co., Ltd. Ester derivatives
AU2002238471B2 (en) * 2000-12-28 2007-06-28 Almirall, S.A. Quinuclidine derivatives and their use as M3 antagonists
KR100944580B1 (ko) * 2001-12-20 2010-02-25 치에시 파마슈티시 에스.피.아. 1-알킬-1-아조니아비시클로[2.2.2]옥탄 카르바메이트유도체 및 이의 무스카린 수용체 길항제로서의 용도
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
EP1900737A1 (fr) * 2006-08-31 2008-03-19 Novartis AG Polymorphe de (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide

Also Published As

Publication number Publication date
IS2746B (is) 2011-08-15
HK1087704A1 (en) 2006-10-20
SI1631569T1 (sl) 2010-01-29
US20100041887A1 (en) 2010-02-18
PL1631569T3 (pl) 2010-02-26
KR100896544B1 (ko) 2009-05-07
ATE440840T1 (de) 2009-09-15
WO2004096800A2 (fr) 2004-11-11
AU2004234069A1 (en) 2004-11-11
AR044134A1 (es) 2005-08-24
PE20050465A1 (es) 2005-07-18
CA2523436A1 (fr) 2004-11-11
EP1631569B1 (fr) 2009-08-26
MXPA05011739A (es) 2006-01-26
EP1631569A2 (fr) 2006-03-08
NZ542995A (en) 2009-02-28
RU2363700C2 (ru) 2009-08-10
US8168654B2 (en) 2012-05-01
DE602004022805D1 (de) 2009-10-08
CL2004000918A1 (es) 2005-02-11
KR20060015572A (ko) 2006-02-17
HRP20050933A2 (en) 2006-12-31
PT1631569E (pt) 2009-11-26
ES2331185T3 (es) 2009-12-23
CA2523436C (fr) 2011-11-01
JP2006525267A (ja) 2006-11-09
RU2005137360A (ru) 2006-07-27
CY1109655T1 (el) 2014-08-13
TW200505920A (en) 2005-02-16
JP4416786B2 (ja) 2010-02-17
WO2004096800A3 (fr) 2005-01-06
IS8158A (is) 2005-11-30
NO20055688D0 (no) 2005-12-01
MY142652A (en) 2010-12-15
ECSP056134A (es) 2006-04-19
CO5700782A2 (es) 2006-11-30
IL171591A (en) 2010-11-30
TWI340139B (en) 2011-04-11
NO20055688L (no) 2006-01-09
AU2004234069B2 (en) 2008-02-21
BRPI0410238A (pt) 2006-05-16
US20070060563A1 (en) 2007-03-15
MA27775A1 (fr) 2006-02-01

Similar Documents

Publication Publication Date Title
DK1631569T3 (da) Quinuclidinderivater, der binder til muscariniske M3-receptorer
DK1730191T3 (da) Immunglobulin som binder HOSM
LTPA2017005I1 (lt) Nauji junginiai, kaip opioido receptoriaus moduliatoriai
DK1572874T3 (da) Antistoffer, der immunospecifikt binder til TRAIL receptorer
ATE380166T1 (de) Hydraulisches bindemittel
NO20055847D0 (no) Nye peptider som binder til erytiupoietinreseptoren
DK1629007T3 (da) Hidtil ukendte peptider som binder til erythropoietin-receptoren
IS3021B (is) Mótefni gegn M-CSF
DE602005027445D1 (de) Neue zusammensetzungen mit chinolin-verbindungen
DK2177537T3 (da) Antistoffer til MAdCAM
DK2215119T3 (da) Monoklonale antistoffer der binder til HGM-CSF og medicinske sammensætninger omfattende de samme.
DK1957517T3 (da) Anvendelse af peptider, der binder til TPO-receptor
DE602006008032D1 (de) Asphaltbindemittel für poröse pflaster
ATE387202T1 (de) Pyrrolidinderivate als histaminrezeptor-liganden
JP2008525358A5 (ja) Ｍ３ムスカリン受容体としてのピロリジニウム誘導体
ZA200608273B (en) Hydraulic binder
DK1812448T3 (da) Organiske forbindelser
DK1539739T3 (da) Piperidinylforbindelser, der selektivt binder integriner
DK1725223T3 (da) Anvendelse af antagonister til CB1-receptoren til fremstilling af en sammensætning, der er anvendelig til behandling af leversygdomme
MA28801B1 (fr) Composition antihistaminique
DK200700967A (da) Omledningsværktöj
DE602005008596D1 (de) Neue tetracyclische tetrahydrofuranderivate
DK1871804T3 (da) Antistoffer, der binder CCX-CKR2
IL190119A0 (en) Amino-alkyl-amide derivatives as ccr3 receptor ligands
IL190093A0 (en) Amino-alkyl-amide derivatives as ccr3 receptor ligands